Bicycle Therapeutics (BCYC) Deferred Taxes (2022 - 2026)
Bicycle Therapeutics (BCYC) posted Deferred Taxes of -$241000.0 for Q1 2026, down 161.95% on a QoQ basis from $389000.0 in Q4 2025, and up 81.69% year-over-year from -$132645.8 in Q1 2025.
Bicycle Therapeutics (BCYC) Deferred Taxes (2022 - 2026) Analysis & Trends
Bicycle Therapeutics' Deferred Taxes history runs 5 years deep, the most recent figure standing at -$241000.0 for Q1 2026.
- Quarterly Deferred Taxes rose 81.69% year-over-year to -$241000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$229000.0 (up 94.7% YoY) and the FY2025 annual result came in at -$1.3 million, up 65.43% from the prior year.
- Deferred Taxes was -$241000.0 for Q1 2026 at Bicycle Therapeutics, down from $389000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $7.3 million in Q3 2023 and bottomed at -$3.3 million in Q3 2024.
- A 5-year average of -$457647.1 and a median of -$767000.0 in 2024 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2023 — Deferred Taxes jumped 810.06% — and 2025, when it tumbled 200.91%.
- Bicycle Therapeutics' Deferred Taxes stood at -$2.3 million in 2022, then soared by 53.98% to -$1.1 million in 2023, then soared by 139.07% to $420000.0 in 2024, then retreated by 7.38% to $389000.0 in 2025, then plunged by 161.95% to -$241000.0 in 2026.
- Business Quant data shows BCYC's Deferred Taxes at -$241000.0 in Q1 2026, $389000.0 in Q4 2025, and -$46000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | -241,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -241,000.00 |
| Dec 31, 2025 | 389,000.00 |
| Sep 30, 2025 | -46,000.00 |
| Jun 30, 2025 | -331,000.00 |
| Mar 31, 2025 | -1.32 Mn |
| Dec 31, 2024 | 420,000.00 |
| Sep 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | -110,000.00 |
| Mar 31, 2024 | -767,000.00 |
| Dec 31, 2023 | -1.08 Mn |
| Sep 30, 2023 | 7.27 Mn |
| Jun 30, 2023 | -1.58 Mn |
| Mar 31, 2023 | -2.11 Mn |
| Dec 31, 2022 | -2.34 Mn |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -868,000.00 |
| Mar 31, 2022 | -748,000.00 |